Polar Asset Management Partners Inc. Intellia Therapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 22,700 shares of NTLA stock, worth $343,224. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,700
Previous 45,200
49.78%
Holding current value
$343,224
Previous $1.01 Million
53.91%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding NTLA
# of Institutions
312Shares Held
91.4MCall Options Held
417KPut Options Held
824K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$185 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$146 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$145 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$77.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$74.8 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.15B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...